Delivery Order SPE2DB24D1205-SPE2DB25FCZJU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,738.69 and an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on September 8, 2025, with a ceiling value of $1,904.63 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $9,379.27 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order is issued without set-aside status, indicating competitive award based on open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency (DLA) awarded a $19,862.57 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a continuation of the company's role as a critical pharmaceutical distributor for federal military and healthcare systems. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections valued at $5,624.52 with a completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $2,176.72 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $14,113.92 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The point of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens valued at $7,129.50. This is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and no set-aside designation was used in the award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a competitively awarded contract, this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $11,387.60. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is set to be completed by September 18, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZJUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,592.97 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the place of performance for this transaction. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military and federal healthcare systems worldwide. The Mounjaro supply supports the Defense Health Agency and other government healthcare programs in their pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 8/8/25 |